Ruipeng Jia
About
In The Last Decade
Ruipeng Jia
33 papers receiving 302 citations
Peers
Comparison fields: 5 of 61
- Surgery 123
- Molecular Biology 101
- Pulmonary and Respiratory Medicine 98
- Biomaterials 69
- Cancer Research 41
Countries citing papers authored by Ruipeng Jia
This map shows the geographic impact of Ruipeng Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruipeng Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruipeng Jia more than expected).
Fields of papers citing papers by Ruipeng Jia
This network shows the impact of papers produced by Ruipeng Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruipeng Jia. The network helps show where Ruipeng Jia may publish in the future.
Co-authorship network of co-authors of Ruipeng Jia
This figure shows the co-authorship network connecting the top 25 collaborators of Ruipeng Jia. A scholar is included among the top collaborators of Ruipeng Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruipeng Jia. Ruipeng Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 6 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | Pan-Cancer Transcriptomic Analysis Identifies PLK1 Crucial for the Tumorigenesis of Clear Cell Renal Cell Carcinoma | 4 |
| 6 | 18 | |
| 7 | 5 | |
| 8 | 12 | |
| 9 | 1 | |
| 10 | 2 | |
| 11 | 11 | |
| 12 | 11 | |
| 13 | 4 | |
| 14 | 49 | |
| 15 | 8 | |
| 16 | 11 | |
| 17 | 9 | |
| 18 | [PDE5: A new therapeutic target for lower urinary tract symptoms/ benign prostatic hyperplasia combined with erectile dysfunction]. | 1 |
| 19 | 44 | |
| 20 | 18 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.